Evidence map›Paper›PMID 39086308›Full record

ArticleHaematologica2024

Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study.

Francesca Kaiser, Monia Lunghi, Deborah Cardinali, Vittorio Bellomarino, Marco Beldinanzi, Irene Della Starza, Francesco Malfona, Claudia M Basilico, Marzia Defina, Sara Mastaglio and 12 more

Abstract read
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Francesca KaiserHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Monia LunghiDivision of Hematology, Department of Translational Medicine, AOU Maggiore della Carità, Università del Piemonte Orientale, Novara.
Deborah CardinaliHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Vittorio BellomarinoHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Marco BeldinanziHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Irene Della StarzaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; AIL ROMA ODV, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Francesco MalfonaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Claudia M BasilicoHematology Department, ASST Settelaghi, Ospedale di Circolo - Fondazione Macchi, Varese.
Marzia DefinaHematology Department, Azienda Ospedaliera Universitaria Senese, Siena.
Sara MastaglioSan Raffaele Scientific Institute, Department of Onco-Hematology, Milan.
Fabio GiglioSan Raffaele Scientific Institute, Department of Onco-Hematology, Milan.
Davide LazzarottoDivision of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), University Hospital of Udine.
Prassede SalutariHematology Department, Ospedale Civile Pescara.
Matteo PicciniHematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence.
Valeria CardinaliSection of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia.
Antonio PieriniSection of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia.
Nicola S FracchiollaFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
Federica Di BiaseDepartment of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Torino, Torino.
Mario AnnunziataHematology Department, Moscati Hospital, Aversa.
Mariangela Di TraniHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Robin FoaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome.
Sabina ChiarettiHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome. chiaretti@bce.uniroma1.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39086308
PMCPMC11609780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.